Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2020-03-12 2020-03-12
Drug Identification Number 02230585 02230585
Brand name TEVA-BROMAZEPAM TEVA-BROMAZEPAM
Common or Proper name BROMAZEPAM 6MG TAB BROMAZEPAM 6MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients BROMAZEPAM BROMAZEPAM
Strength(s) 6MG 6MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-03-05 2020-03-05
Estimated end date 2020-03-31 2020-03-31
Actual end date 2020-03-11 2020-03-11
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments